Explainer | Could a head lice drug hold the key to treating coronavirus?
- Recent research data from scientists in Australia suggests Ivermectin is able to stop SARS-CoV-2, the virus that causes Covid-19, from replicating
- But it’s still too soon to know if the promising laboratory test results will translate into a safe and effective drug for coronavirus patients
Researchers testing the head lice drug Ivermectin as a possible treatment for Covid-19 have seen promising results in laboratory studies.
But the research is in its early stages and the drug is yet to be tested on people with Covid-19. There’s so much we don’t know, including the right dose and delivery method for people with coronavirus infection.
So if you’re thinking of buying some just in case, think again.
What is Ivermectin currently used for?
Ivermectin is an antiparasitic agent that was isolated in the 1970s from the fermented broth of a species of bacteria called Streptomyces avermitilis.
The drug has been used since the 1980s to treat and prevent diseases related to parasites in humans, pets and livestock, and works by paralysing invertebrate parasites.